Current status of erythrocyte substitutes.

Area of Science:

• Biomedical Engineering
• Hematology
• Transfusion Medicine

Background:

• The demand for blood transfusions necessitates the development of alternatives.
• Current alternatives include hemoglobin-based oxygen carriers and fluorocarbon emulsions.
• These substitutes are not blood-type-specific, offering a universal application.

Purpose of the Study:

• To review recent developments in erythrocyte substitutes.
• To identify challenges and recent advances in hemoglobin solutions and fluorocarbon emulsions.
• To assess the clinical utility of emerging blood substitutes.

Main Methods:

• Literature review of advancements in erythrocyte substitute research over the past two decades.
• Analysis of modifications required for hemoglobin solutions and fluorocarbon emulsions.
• Evaluation of recent breakthroughs addressing limitations in oxygen affinity, persistence, and delivery.

Main Results:

• Hemoglobin solutions require reduced oxygen affinity and improved intravascular persistence.
• Fluorocarbon emulsions necessitate hyperbaric oxygen for significant oxygen supply.
• Recent scientific progress is addressing these critical modifications for clinical viability.

Conclusions:

• Erythrocyte substitutes show significant promise as alternatives to whole blood transfusions.
• Further modifications are essential for the clinical application of hemoglobin solutions and fluorocarbons.
• Ongoing research is paving the way for effective blood substitute therapies.